Status:
WITHDRAWN
iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This trial investigates whether an online intervention, iConquerFear, can reduce fear of cancer coming back (recurrence) and anxiety in patients with renal cell carcinoma that is restricted to the sit...
Detailed Description
PRIMARY OBJECTIVES: I. To assess feasibility and acceptability of the iConquerFear program for patients with renal cell carcinoma (RCC). II. To assess preliminary effects of the program on Fear of C...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Sufficiently fluent in English
- Cytologically or pathologically verified diagnosis of RCC
- Undergone nephrectomy with negative margins (NOTE: Patients with other local definitive therapies, e.g., radiofrequency ablation or stereotactic ablative radiotherapy \[SABR\], would not be candidates for this protocol)
- No evidence of metastatic disease (including at a minimum computed tomography \[CT\] of the chest, abdomen and pelvis for staging)
- Internet access and basic computer skills
- Moderate to severe fear of cancer recurrence (FCR)
Exclusion
Key Trial Info
Start Date :
August 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 27 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04688333
Start Date
August 20 2022
End Date
August 27 2023
Last Update
June 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.